Guidance for Industry and Food and Drug Administration Review Staff: Collection of Platelets by Automated Methods; Availability

Özet

The Food and Drug Administration (FDA) is announcing the availability of a document entitled "Guidance for Industry and FDA Review Staff: Collection of Platelets by Automated Methods," dated December 2007. The guidance document provides to blood establishments and FDA staff revised recommendations for the collection of Platelets by automated methods (plateletpheresis). The guidance is intended to help blood establishments ensure donor safety and the safety, purity, and potency of Platelets collected by an automated blood cell separator device. For the purpose of this document, Platelets collected by automated methods will be referred to by the product name "Platelets, Pheresis." The document contains recommendations for appropriate criteria for a biologics license application or supplement for manufacturing Platelets, Pheresis. The guidance announced in this notice finalizes the draft guidance of the same title dated September 2005, and supersedes the guidance entitled "Revised Guideline for the Collection of Platelets, Pheresis," dated October 1988.